Craft
Reapplix

Reapplix

Total Funding

$1.7 M

Reapplix Summary

Company summary

Overview
Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers. It develops 3C Patch System that identifies blood-derived proteins that improve wound healing.
Type
Private
Founded
2008
HQ
Birkerød, DK | view all locations
Website
https://reapplix.com/
Cybersecurity rating
Sectors

Key people

  • Ulrik Spork, Chairman

    • Rasmus Lundquist

      Rasmus Lundquist, Chief Scientific Officer

      • Morten Have Rasmussen

        Morten Have Rasmussen, Chief Financial Officer

        • Christian Vollmar

          Christian Vollmar, Vp Global Marketing & European Sales

          LocationsView all

          2 locations detected

          • Birkerød HQ

            Denmark

            Blokken 45

          • Southlake, TX

            United States

            325 Miron Dr #140

          Footer menu